Kavar Capital Partners Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Kavar Capital Partners Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-175	Closed	-$55K	–	378
2019 Q2	$55K	Buy	+175	New	+$58.3K	0.02%	222
2018 Q3	–	Sell	-175	Closed	-$60K	–	315
2018 Q2	$60K	Hold	175	–	–	0.03%	171
2018 Q1	$60K	Buy	+175	New	+$60.9K	0.03%	170
2016 Q1	–	Sell	-175	Closed	-$95K	–	323
2015 Q4	$95K	Sell	175 -50	-22%	-$27.1K	0.06%	133
2015 Q3	$104K	Hold	225	–	–	0.07%	129
2015 Q2	$114K	Buy	+225	New	+$110K	0.08%	137
2014 Q2	–	Sell	-4	Closed	-$1K	–	365
2014 Q1	$1K	Buy	+4	New	+$1.23K	﹤0.01%	467

Other funds holding REGN

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates

Harris Associates Chicago, Illinois $74.9B AUM 11.27% 1-Year Est. Return

Loomis, Sayles & Company

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return